These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1366117)

  • 1. [Can muscular dystrophy be treated?].
    Somer H
    Duodecim; 1992; 108(6):575-7. PubMed ID: 1366117
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunosuppressive therapy in Duchenne muscular dystrophy: considerations for myoblast transfer studies.
    Mendell JR
    Adv Exp Med Biol; 1990; 280():287-95. PubMed ID: 2248150
    [No Abstract]   [Full Text] [Related]  

  • 3. Myoblast transplantation in inherited myopathies.
    Morgan JE; Watt DJ
    Mol Cell Biol Hum Dis Ser; 1993; 3():303-31. PubMed ID: 8111544
    [No Abstract]   [Full Text] [Related]  

  • 4. Muscular dystrophy. Muscling in on gene therapy.
    Blau HM
    Nature; 1993 Aug; 364(6439):673-5. PubMed ID: 8355780
    [No Abstract]   [Full Text] [Related]  

  • 5. Gene therapy for Duchenne dystrophy.
    Engel AG
    Ann Neurol; 1993 Jul; 34(1):3-4. PubMed ID: 8517677
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatments for muscular dystrophy: increased treatment options for Duchenne and related muscular dystropies.
    Wells DJ
    Gene Ther; 2008 Aug; 15(15):1077-8. PubMed ID: 18528429
    [No Abstract]   [Full Text] [Related]  

  • 7. Loss of myostatin attenuates severity of muscular dystrophy in mdx mice.
    Wagner KR; McPherron AC; Winik N; Lee SJ
    Ann Neurol; 2002 Dec; 52(6):832-6. PubMed ID: 12447939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muscular dystrophy meets the mesangioblast.
    Schubert C
    Nat Med; 2003 Aug; 9(8):999. PubMed ID: 12894161
    [No Abstract]   [Full Text] [Related]  

  • 9. Platelet-derived growth factor and its receptors are related to the progression of human muscular dystrophy: an immunohistochemical study.
    Zhao Y; Haginoya K; Sun G; Dai H; Onuma A; Iinuma K
    J Pathol; 2003 Sep; 201(1):149-59. PubMed ID: 12950028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrotransfer of naked DNA in the skeletal muscles of animal models of muscular dystrophies.
    Vilquin JT; Kennel PF; Paturneau-Jouas M; Chapdelaine P; Boissel N; Delaère P; Tremblay JP; Scherman D; Fiszman MY; Schwartz K
    Gene Ther; 2001 Jul; 8(14):1097-107. PubMed ID: 11526457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treating muscular dystrophy with stem cells?
    Davies KE; Grounds MD
    Cell; 2006 Dec; 127(7):1304-6. PubMed ID: 17190595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress in myoblast transplantation: a potential treatment of dystrophies.
    Skuk D; Tremblay JP
    Microsc Res Tech; 2000 Feb 1-15; 48(3-4):213-22. PubMed ID: 10679968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic improvement of dystrophic muscles by rAAV/microdystrophin vectors is augmented by Igf1 codelivery.
    Abmayr S; Gregorevic P; Allen JM; Chamberlain JS
    Mol Ther; 2005 Sep; 12(3):441-50. PubMed ID: 16099410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscular dystrophies and stem cells: a therapeutic challenge.
    Rivier F; Gussoni E
    Cytotherapy; 2002; 4(6):513-9. PubMed ID: 12568986
    [No Abstract]   [Full Text] [Related]  

  • 15. Identification of a putative pathway for the muscle homing of stem cells in a muscular dystrophy model.
    Torrente Y; Camirand G; Pisati F; Belicchi M; Rossi B; Colombo F; El Fahime M; Caron NJ; Issekutz AC; Constantin G; Tremblay JP; Bresolin N
    J Cell Biol; 2003 Aug; 162(3):511-20. PubMed ID: 12885758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dominant-negative inhibition of Ca2+ influx via TRPV2 ameliorates muscular dystrophy in animal models.
    Iwata Y; Katanosaka Y; Arai Y; Shigekawa M; Wakabayashi S
    Hum Mol Genet; 2009 Mar; 18(5):824-34. PubMed ID: 19050039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification and proliferation of human myoblasts isolated with fluorescence activated cell sorting.
    Blau HM; Webster C; Pavlath GK
    Adv Exp Med Biol; 1990; 280():97-100. PubMed ID: 2248160
    [No Abstract]   [Full Text] [Related]  

  • 18. Myoblast transfer in Duchenne muscular dystrophy.
    Karpati G; Ajdukovic D; Arnold D; Gledhill RB; Guttmann R; Holland P; Koch PA; Shoubridge E; Spence D; Vanasse M
    Ann Neurol; 1993 Jul; 34(1):8-17. PubMed ID: 8517684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pilot study of myoblast transfer in the treatment of Becker muscular dystrophy.
    Neumeyer AM; Cros D; McKenna-Yasek D; Zawadzka A; Hoffman EP; Pegoraro E; Hunter RG; Munsat TL; Brown RH
    Neurology; 1998 Aug; 51(2):589-92. PubMed ID: 9710042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphocyte infiltration following allo- and xenomyoblast transplantation in mdx mice.
    Guérette B; Asselin I; Vilquin JT; Roy R; Tremblay JP
    Muscle Nerve; 1995 Jan; 18(1):39-51. PubMed ID: 7799997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.